Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adenovirus
Biotech
Vertex discontinues AAV research for gene therapies
Despite the shift away from AAVs, a company spokesperson affirmed that Vertex’s “commitment to cell and genetic therapies remains strong.”
Darren Incorvaia
May 2, 2025 6:22pm
Lilly saves gene therapy biotech with $18M upfront deal
Apr 3, 2025 6:00pm
Roche bets up to $1B to expand Dyno gene therapy delivery pact
Oct 24, 2024 10:40am
Labcorp nets companion Dx OK for Pfizer hemophilia gene therapy
Apr 29, 2024 1:56pm
Voyager asset lands on planet Alexion after Pfizer handoff
Nov 6, 2023 4:01pm
Team behind AstraZeneca's COVID shot reunites on pandemic prep
Aug 30, 2023 10:40am
